Huakang Biomedical (08622) announced that the company's board of directors was awarded the company's controlling shareholder Crystal Gr...
According to Zhitong Finance App News, Huakang Biomedical (08622) issued an announcement. The company's board of directors was notified by Crystal Grant Limited, the controlling shareholder of the company. On January 9, 2024, Crystal Grant sold 5.36 million shares of the company's shares on the open market, accounting for about 1.28% of the company's total issued share capital at the date of this announcement. In-market transactions were carried out at an average price of about HK$0.152 per share on the Stock Exchange trading platform.
Immediately following the sale, the number of shares held by Crystal Grant was reduced from 144 million shares (accounting for about 34.42% of the company's total issued share capital) to 139 million shares (accounting for about 33.14% of the company's total issued share capital).